COVID-19 publications by Rochester Regional Health authors.
Submissions from 2023
1-13-2023 Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated, Jill Maaske, Clinical Development, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States., Stephanie Sproule, Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States., Ann R. Falsey, Rochester Regional Health, et al.
1-10-2023 Infectious Complications After Tocilizumab in Patients with COVID: A Real-World Experience, Hongli Liu, Rochester Regional Health, Chengu Niu, Rochester Regional Health, Ahmed Elkhapery, Rochester Regional Health, et al.
1-5-2023 Public Health in Monroe County: Past, Present, and Future, Michael Mendoza, Monroe County Department of Public Health, Rochester, NY
1-1-2023 A Comparison of the Effects of COVID-19 on Irritable Bowel Syndrome and Inflammatory Bowel Disease Patients While Working at Home and in the Office: A Retrospective Study, Spyridon Zouridis, Albany Medical Center, Albany, USA, Muhammad Farhan Ashraf, Rochester Regional Health, Patrick Tempera, Albany Medical Center, Albany, USA, et al.
1-2023 Impact of COVID-19 in patients hospitalized with stress cardiomyopathy: A nationwide analysis, Adrija Hajra, Department of Internal Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA., Aaqib Malik, Department of Cardiology, Westchester Medical Center, New York Medical College, Valhalla, NY, USA., Dhrubajyoti Bandyopadhyay, Department of Cardiology, Westchester Medical Center, New York Medical College, Valhalla, NY, USA., et al.
Submissions from 2022
12-23-2022 Association of hypernatremia with outcomes of COVID-19 patients: A protocol for systematic review and meta-analysis, Abhigan Babu Shrestha, M Abdur Rahim Medical College, Dinajpur, Bangladesh., Unnat Hamal Sapkota, M Abdur Rahim Medical College, Dinajpur, Bangladesh., Sajina Shrestha, Kist Medical College, Imadol, Patan, Nepal., et al.
12-8-2022 Adult Onset Nephrotic Syndrome Post COVID-19 Infection, Pulkit Gandhi, Rochester Regional Health; Marvin Grieff, Rochester Regional Health; and Arjun Sekar, Rochester Regional Health
12-1-2022 1953. Immune responses, viral shedding, and COVID-19 symptom burden from breakthrough SARS-CoV-2 infection in a 2:1 randomized, double-blind, placebo-controlled Phase 3 study of AZD1222 (ChAdOx1 nCoV-19) vaccination, Magdalena E. Sobieszczyk, New York-Presbyterian Columbia University Irving Medical Center and Ann R. Falsey, Rochester Regional Health
12-2022 An overview of third, fourth and sixth cranial nerve palsies in the setting of COVID-19: A case report and systematic review, Mostafa Meshref, l-Azhar University, Cairo, Egypt; Nour Shaheen, Alexandria University, Alexandria Faculty of Medicine, Alexandria, Egypt; and Mostafa Reda Mostafa, Rochester Regional Health
11-8-2022 Abstract 14503: Cardiac Arrest Secondary to Inferior ST-Segment Elevation Myocardial Infarction in Patient With Paroxysmal Nocturnal Hemoglobinuria and COVID 19 Infection, Mohamed Salah Mohamed, Rochester Regional Health, Amr Salama, Rochester Regional Health, Anas M. Hashem, Rochester Regional Health, et al.
11-2022 Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized with COVID-19: A Blinded Randomized Placebo-Controlled Trial, Wesley H. Self, Vanderbilt University Medical Center; Allison P. Wheeler, Vanderbilt University Medical Center, Nashville, Tennessee; and Maryrose Laguio-Vila, Rochester Regional Health
10-13-2022 Health Informatics and the Covid-19 Pandemic: Challenges, Opportunities, Lessons learned and the path ahead, Venugopal Mudgundi, Rochester Regional Health; Farhad Nasar, Rochester Regional Health; and Balazs Zsenits, Rochester Regional Health
10-10-2022 Old drugs, new tricks: leveraging known compounds to disrupt coronavirus-induced cytokine storm, Spencer Richman, Rochester Regional Health, Cole Lyman, Rochester Regional Health, Anastasia Nesterova, Elsevier BV, Biology Solutions, Amsterdam, the Netherlands., et al.
10-1-2022 Developing patient-centered outcomes research infrastructure in a rural community through patient and stakeholder engagement and education during the COVID-19 pandemic, Carly Lovelett, Rochester Regional Health, Michelle Medeiros, The PATIENTS Program, University of Maryland School of Pharmacy, Baltimore, MD, USA., Daniel Jaremczuk, Rochester Regional Health, et al.
9-30-2022 Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial, Alaa Rahhal, Hamad Medical Corporation, Doha, Qatar; Mostafa Najim, Rochester Regional Health; and Amer Hussein Aljundi, Hamad Medical Corporation, Doha, Qatar
9-15-2022 Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months, Magdalena E Sobieszczyk, Columbia University Irving Medical Center, New York, New York, Jill Maaske, AstraZeneca, Gaithersburg, Maryland, Ann R. Falsey, Rochester Regional Health, et al.
6-10-2022 Pandemic Preparedness: COVID-19 Lessons Learned in New York's Hospitals: COVID-19 Lessons Learned in New York's Hospitals, Mark Jarrett, HANYS's Statewide Steering Committee on Quality Initiatives; Renee Garrick, HANYS's Statewide Steering Committee on Quality Initiatives; and Robert Mayo, Rochester Regional Health
6-1-2022 COVID vaccine immune response in patients with plasma cell dyscrasia: A systematic review, Unaiza Faizan, Rochester Regional Health, Lakshmi G. Nair, Rochester Regional Health, James Evans, Rochester Regional Health, et al.
Emerging trends in healthcare driven by the COVID-19 pandemic: A review from Health Informatics Perspective., Venugopal Mudgundi, Bhargav Desai, and Farhad Nasar
5-23-2022 Patient and Clinician Attitudes Towards Telemedicine for Allergy and Immunology, Allison Ramsey, Rochester Regional Health; S Shahzad Mustafa, Rochester Regional Health; and Jay Portnoy, Section of Allergy, Asthma & Immunology. Children's Mercy Hospital, Kansas City, MO
5-17-2022 Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis, Gianluigi Li Bassi, University of Queensland, Brisbane, Australia, Kristen Gibbons, University of Queensland, Brisbane, Australia, The COVID-19 Critical Care Consortium, et al.
5-13-2022 Assessment of Bleeding Risk in Hospitalized COVID-19 Patients: A Tertiary Hospital Experience during the Pandemic in a Predominant Minority Population-Bleeding Risk Factors in COVID-19 Patients, Hesham Abowali, One Brooklyn Health, Brookdale Hospital, Brooklyn, NY 11212, USA., Antoinette Pacifico, Baystate Medical Center, Springfield, MA 01199, USA., Burak Erdinc, SUNY Downstate Medical Center, Brooklyn, NY 11203, USA., et al.
5-1-2022 Abstract 271: Bradyarrhythmia Associated With Remdesivir And Covid-19 Pneumonia: A Pharmacovigilance Analysis, Krutarth K. Pandya, Trumbull Regional Med Cntr, Western Reserve Health Education, Warren, OH, Parth R. Shah, Trumbull Regional Med Cntr, Western Reserve Health Education, Warren, OH, Harsh P. Patel, Louis A. Weiss Memorial Hospital, Chicago, Illinois., et al.
4-20-2022 Post-COVID-19 Impairment of the Senses of Smell, Taste, Hearing, and Balance, Sonja Ludwig, University Hospital Mannheim; Angela Schell, University Hospital Mannheim; and Alexander Kusnik, Rochester Regional Health
4-14-2022 Guillain-Barré syndrome after mRNA-1273 (Moderna) COVID-19 vaccination: A case report, Zauraiz Anjum, Rochester Regional Health, Charoo Iyer, Rochester Regional Health, Maryrose Laguio-Vila, Rochester Regional Health, et al.